BIOMARKER:

Chr del(11)(q22.3)

B | Sensitive

C3 | Sensitive

B | Resistant

C3 | Resistant

Show legend

Drug categories

Tyrosine Kinase Inhibitors

CD Protein Inhibitors

Immunotherapy

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

acalabrutinib

Chr del(11)(q22.3)|Chronic Lymphocytic Leukemia|acalabrutinib

Chr del(11)(q22.3)|Small Lymphocytic Lymphoma|acalabrutinib

ibrutinib

Chr del(11)(q22.3)|Chronic Lymphocytic Leukemia|ibrutinib

ibrutinib + rituximab

Chr del(11)(q22.3)|Chronic Lymphocytic Leukemia|ibrutinib + rituximab

alemtuzumab

Chr del(11)(q22.3)|Chronic Lymphocytic Leukemia|alemtuzumab